Form 8-K - Current report:
SEC Accession No. 0001023024-25-000113
Filing Date
2025-12-01
Accepted
2025-12-01 06:58:48
Documents
14
Period of Report
2025-11-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20251124.htm   iXBRL 8-K 29016
2 EX-99.1 anip-20251124xexx991.htm EX-99.1 14338
6 a1a.jpg GRAPHIC 5505
  Complete submission text file 0001023024-25-000113.txt   171158

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20251124.xsd EX-101.SCH 1755
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20251124_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20251124_pre.xml EX-101.PRE 12491
16 EXTRACTED XBRL INSTANCE DOCUMENT ani-20251124_htm.xml XML 2690
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)